ailanthoidol

from Zanthoxylum ailanthoidos; structure in first source

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

1.	Septic Shock (Toxic Shock Syndrome) 12/01/2011 - "Here, we report that ailanthoidol inhibits inflammatory reactions in macrophages and protects mice from endotoxin shock. " 06/01/2013 - "We reported that ailanthoidol, a neolignan from Zanthoxylum ailanthoides and Salvia miltiorrhiza Bunge, inhibited inflammatory reactions by macrophages and protected mice from endotoxin shock. " 12/01/2011 - "In an animal model, ailanthoidol protected BALB/c mice from LPS-induced endotoxin shock, possibly through inhibition of the production of inflammatory cytokines and NO. Collectively, ailanthoidol inhibited the production of inflammatory mediators and may be a potential target for treatment of various inflammatory diseases." 12/01/2011 - "Ailanthoidol suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice."
2.	Hepatoblastoma 08/30/2021 - "Ailanthoidol, a Neolignan, Suppresses TGF-β1-Induced HepG2 Hepatoblastoma Cell Progression."
3.	Neoplasms (Cancer) 10/01/2006 - "Inhibitory effect of ailanthoidol on 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion in mouse skin."
4.	Hepatocellular Carcinoma (Hepatoma) 05/04/2022 - "Suppression of the Proliferation of Huh7 Hepatoma Cells Involving the Downregulation of Mutant p53 Protein and Inactivation of the STAT 3 Pathway with Ailanthoidol."